Company profile

Amaroq Therapeutics

Industry
Biotechnology
Employees
7
Headquarters
Auckland
Office locations
1

Amaroq Therapeutics company summary

Amaroq Therapeutics is a company in the Biotechnology industry, headquartered in Auckland. On LinkedIn the company has around 7 employees.

What technology does Amaroq Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Amaroq Therapeutics

Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer. Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as “dark matter” of the human genome. These naturally occurring molecules do not code for proteins but fulfill important regulatory functions in the cell that could be exploited as a new therapeutic approach for multiple indications. Amaroq’s research team has discovered lncRNA molecules that are highly expressed in cancer cells, and once removed, cancer cell growth slows. Amaroq Therapeutics is developing innovative therapeutics to target lncRNAs for cancer treatment. Amaroq Therapeutics is funded by the Medical Research Commercialisation Fund, managed by life science venture capital firm Brandon Capital Partners, Otago Innovation Ltd, University of Otago, Cure Kids, and NZ Innovation Booster. The Company has been spun out of research from the University of Otago in Dunedin, New Zealand.

Where is Amaroq Therapeutics located?

Amaroq Therapeutics lists 1 location.

Auckland, 1010, NZHQ
15 Customs St W

Compare companies similar to Amaroq Therapeutics

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Amaroq Therapeutics
amaroqtx.com
Biotechnology7-Auckland
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Amaroq Therapeutics

What does Amaroq Therapeutics do?

Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer. Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as “dark matter” of the human genome. These naturally occurring molecules do not code for proteins but fulfill important regulatory functions in the cell that could be exploited as a new therapeutic approach for multiple indications. Amaroq’s research team has discovered lncRNA molecules that are highly expressed in cancer cells, and once removed, cancer cell growth slows. Amaroq Therapeutics is developing innovative therapeutics to target lncRNAs for cancer treatment. Amaroq Therapeutics is funded by the Medical Research Commercialisation Fund, managed by life science venture capital firm Brandon Capital Partners, Otago Innovation Ltd, University of Otago, Cure Kids, and NZ Innovation Booster. The Company has been spun out of research from the University of Otago in Dunedin, New Zealand.

How many employees does Amaroq Therapeutics have?

Amaroq Therapeutics has around 7 employees on LinkedIn.

Where is Amaroq Therapeutics headquartered?

Amaroq Therapeutics is headquartered in Auckland.

Build a lead list from companies like Amaroq Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.